Ποια είναι η τιμή για D. Western Therapeutics Institute, Inc. (4576)

Η τιμή για D. Western Therapeutics Institute, Inc. (4576) είναι $0.5676202

Ποια είναι η κεφαλαιοποίηση αγοράς για D. Western Therapeutics Institute, Inc. (4576)

Η κεφαλαιοποίηση αγοράς για D. Western Therapeutics Institute, Inc. (4576) είναι $32.62M

D. Western Therapeutics Institute, Inc. (4576) Δείκτης P/E

D. Western Therapeutics Institute, Inc. is a biotechnology enterprise focused on the research, discovery, and innovation of various pharmaceutical drugs. The company's current portfolio includes GLANATEC and GLA-ALPHA, ophthalmic solutions prescribed for glaucoma and ocular hypertension, as well as DW-1001, another medication for eye conditions. It also provides DWR-2206, a regenerative cell-based product targeting bullous keratopathy, and DW-1002, an ophthalmic surgical aid used for staining membranes like ILM, ALC, ERM, and PVR during cataract operations. In its development pipeline, the company is advancing DW-5LBT, a lidocaine patch designed to alleviate neuropathic pain post-shingles. Additionally, K-321 is progressing through Phase III clinical trials for Fuch endothelial corneal dystrophy, and H-1337, a multi-kinase inhibitor, has commenced Phase IIb trials for glaucoma and ocular hypertension treatment. The firm was established in 1999 and operates from its headquarters in Nagoya, Japan.

Έτος	Αναλογία P/E	Αλλαγή
Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.

Έτος

Αναλογία P/E

Αλλαγή

Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.

Εταιρεία	P/E Ratio	Διαφορά P/E Ratio	Χώρα
Vertex Pharmaceuticals Incorporated VRTX.US	29.20	-	US
Moderna, Inc. MRNA.US	-7.93	-	US
Argenx SE ARGX.US	30.62	-	NL
CSL Limited CSL.AX	32.46	-	AU
Lonza Group AG LONN.SW	-	-	CH

Εταιρεία

P/E Ratio

Διαφορά P/E Ratio

Χώρα